Seelos therapeutics announces updates to sls-005 programs for europe and u.s.

Seelos therapeutics announces updates to sls-005 (trehalose) programs for europe and u.s..seelos - scheduled meeting in march 2020 with ema to seek assistance for european study of sls-005 in patients with sanfillipo syndrome type a & b.seelos therapeutics- submitted to fda, protocol for study for sanfilippo syndrome type a & b patients who don't meet phase iib/iii trial entry criteria.seelos therapeutics inc - continues to pursue plans to develop sls-005 in oculopharyngeal muscular dystrophy.seelos therapeutics- submitted to fda, protocol for study for sanfilippo syndrome type c & d patients who don't meet phase iib/iii trial entry criteria.
SEEL Ratings Summary
SEEL Quant Ranking